Sensex, Nifty muted a day after sharp rally, IT stocks extend gains. What lies ahead for Dalal Street?
BSE moved lower.
· Economic Times Markets, ET Stocks
Indian equities traded nearly flat after a sharp rally in the previous session, with IT stocks extending gains while pharma shares declined. Analysts flagged elevated US bond yields and crude oil prices as headwinds, even as short-covering and hopes of tax relief supported sentiment.
The analysis
This is an Input cost / crude event. India imports most of its crude, so input costs pass through to margins downstream and to the rupee. Producers and consumers of the same input move in opposite directions.
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Why it matters
- With BSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- A market-wide development: it reaches beyond any single stock.
- Sectors in the story: Pharma & Healthcare.
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Nifty IT’s 18% rally may mark a durable leadership cycle; 35,000 next: LKP's Vatsal Bhuva
Bonus share: Just single issue with record date this week: Pharma firm's free shares with 68% returns since IPO; ratio
Pharma company Gufic buys Lodha Avalon duplex in Juhu for ₹236 crore
Nifty Pharma index hits record high; Sun, Laurus, Zydus, Sai rally up to 6%
Regulator orders Sun Pharma to shut Assam plant over eye-drop quality lapses; what you should know